IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms

被引:42
|
作者
Chalubinski, Maciej [1 ]
Wojdan, Katarzyna [1 ]
Luczak, Emilia [1 ]
Gorzelak, Paulina [1 ]
Borowiec, Maciej [2 ,3 ]
Gajewski, Adrian [4 ]
Rudnicka, Karolina [4 ]
Chmiela, Magdalena [4 ]
Broncel, Marlena [1 ]
机构
[1] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lab Tissue Immunopharmacol, PL-91347 Lodz, Poland
[2] Med Univ Lodz, Dept Pediat Oncol Hematol & Diabetol, Immunopathol & Genet Lab, PL-91738 Lodz, Poland
[3] Med Univ Lodz, Dept Clin Genet, PL-90425 Lodz, Poland
[4] Univ Lodz, Lab Gastroimmunol, Dept Immunol & Infect Biol, Fac Biol & Environm Protect, PL-90131 Lodz, Poland
关键词
IL-33; IL-4; Endothelium; Barrier functions; Tight junctions; Tissue injury; IN-VIVO; TIGHT JUNCTIONS; IFN-GAMMA; CELLS; INTERLEUKIN-4; CADHERIN; PERMEABILITY; ACTIVATION; EXPRESSION; INCREASES;
D O I
10.1016/j.vph.2015.07.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The vascular endothelium forms a barrier that controls flow of solutes and proteins and the entry of leukocytes into tissue. Injured tissue releases IL-33, which then alarms the immune system and attracts Th2 cells, thus increasing local concentration of IL-4. The aim of the study was to assess the influence of IL-33 and IL-4 on barrier functions of the human endothelium, expression of tight and adherent junction proteins, apoptosis and adhesive molecule surface expression in human endothelium in order to describe the mechanism of this effect. IL-33 and IL-4 decreased endothelial integrity and increased permeability. When added together, both cytokines lowered the endothelial integrity twice as much as used alone. This effect was accompanied by the down-regulation of occludin and VE-cadherin mRNA expression. Additionally, IL-4, but not IL-33, induced cell apoptosis. Both IL-33 and IL-4 showed the additive potency to down-regulate VE-cadherin mRNA expression. IL-33, unlike IL-4, increased the surface expression of ICAM-1, but not PECAM-1 in endothelial cells. Our results indicate that IL-33 may reversibly destabilize the endothelial barrier, thus accelerating the supply with immunomodulators and assisting leukocytes to reach wounded tissue. However, extended and less-controlled down-regulation of endothelial barrier, which may be a consequence of IL-33-initiated, but in fact IL-4-induced apoptosis of endothelial cells, may be deleterious and may eventually lead to the aggravation of inflammatory processes and the prolongation of tissue dysfunction. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 50 条
  • [21] Dermal White Adipose Tissue-Derived Il-33 Regulates Il-4/13 Expression in Myeloid Cells Inflammation
    Ertel, Anastasia
    Anderegg, Ulf
    Franz, Sandra
    Saalbach, Anja
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2025, 145 (02) : 370 - 382
  • [22] IFNγ and IL-4 regulate secretory and barrier functions in epithelial cells.
    Venglarik, CJ
    Kirk, KL
    Jilling, T
    FASEB JOURNAL, 1998, 12 (05): : A675 - A675
  • [23] IL-33 Induces IL-9 Production in Human CD4+ T Cells and Basophils
    Blom, Lars
    Poulsen, Britta C.
    Jensen, Bettina M.
    Hansen, Anker
    Poulsen, Lars K.
    PLOS ONE, 2011, 6 (07):
  • [24] IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4
    Kurowska-Stolarska, Mariola
    Kewin, Pete
    Murphy, Grace
    Russo, Remo C.
    Stolarski, Bartosz
    Garcia, Cristiana Couto
    Komai-Koma, Mousa
    Pitman, Nick
    Li, Yubin
    McKenzie, Andrew N. J.
    Teixeira, Mauro M.
    Liew, Foo Y.
    Xu, Damo
    JOURNAL OF IMMUNOLOGY, 2008, 181 (07): : 4780 - 4790
  • [25] IL-33/13 Axis and IL-4/31 Axis Play Distinct Roles in Inflammatory Process and Itch in Psoriasis and Atopic Dermatitis
    Bodoor, Khaldon
    Al-Qarqaz, Firas
    Al Heis, Leen
    Alfaqih, Mahmoud A.
    Oweis, Ashraf O.
    Almomani, Rowida
    Obeidat, Motaz A.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2020, 13 : 419 - 424
  • [26] The role of IL-33/ST2, IL-4, and eosinophils on the airway hyperresponsiveness induced by Strongyloides venezuelensis in BALB/c mice
    Araujo, Emilia Souza
    de Jesus Pereira, Cintia Aparecida
    de Moura Pereira, Ana Terezinha
    Peixoto Moreira, Joao Marcelo
    de Rezende, Michelle Carvalho
    Rodrigues, Jailza Lima
    Teixeira, Mauro Martins
    Negrao-Correa, Deborah
    PARASITOLOGY RESEARCH, 2016, 115 (08) : 3107 - 3117
  • [27] The role of IL-33/ST2, IL-4, and eosinophils on the airway hyperresponsiveness induced by Strongyloides venezuelensis in BALB/c mice
    Emilia Souza Araujo
    Cintia Aparecida de Jesus Pereira
    Ana Terezinha de Moura Pereira
    João Marcelo Peixoto Moreira
    Michelle Carvalho de Rezende
    Jailza Lima Rodrigues
    Mauro Martins Teixeira
    Deborah Negrão-Corrêa
    Parasitology Research, 2016, 115 : 3107 - 3117
  • [28] A humanized mouse model to study asthmatic airway inflammation via the human IL-33/IL-13 axis
    Ito, Ryoji
    Maruoka, Shuichiro
    Soda, Kaori
    Katano, Ikumi
    Kawai, Kenji
    Yagoto, Mika
    Hanazawa, Asami
    Takahashi, Takeshi
    Ogura, Tomoyuki
    Goto, Motohito
    Takahashi, Riichi
    Toyoshima, Shota
    Okayama, Yoshimichi
    Izuhara, Kenji
    Gon, Yasuhiro
    Hashimoto, Shu
    Ito, Mamoru
    Nunomura, Satoshi
    JCI INSIGHT, 2018, 3 (21):
  • [29] A Humanized Mouse Model to Study Asthmatic Airway Inflammation Via Human IL-33/IL-13 Axis
    Maruoka, S.
    Yamada, S.
    Ito, R.
    Nunomura, S.
    Toyoshima, S.
    Okayama, Y.
    Izuhara, K.
    Hashimoto, S.
    Gon, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [30] Microbial dysbiosis in a mouse model of atopic dermatitis mimics shifts in human microbiome and correlates with the key pro-inflammatory cytokines IL-4, IL-33 and TSLP
    Amar, Y.
    Schneider, E.
    Koberle, M.
    Seeholzer, T.
    Musiol, S.
    Hoelge, I. M.
    Gschwendtner, S.
    Krappmann, D.
    Steiger, K.
    Biedermann, T.
    Schmidt-Weber, C. B.
    Alessandrini, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (05) : 705 - 716